ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

TARA Protara Therapeutics Inc

2.91
0.02 (0.69%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Protara Therapeutics Inc TARA NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.02 0.69% 2.91 23:00:01
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
2.91 2.835 2.99 2.91 2.89
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
02/5/202407:00GLOBEProtara Therapeutics Announces First Quarter 2024 Financial..
05/4/202407:04GLOBEProtara Therapeutics Announces Oversubscribed $45 Million..
05/4/202407:02GLOBEProtara Therapeutics Announces Alignment with FDA on..
05/4/202407:00GLOBEProtara Therapeutics Announces Positive Three-Month Data..
13/3/202407:00GLOBEProtara Therapeutics Announces Fourth Quarter and Full Year..
28/2/202407:00GLOBEProtara Therapeutics to Present at the TD Cowen 44th Annual..
23/1/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202415:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202415:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/11/202307:30GLOBEProtara Therapeutics Announces Presentation of Additional..
14/11/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
03/11/202307:31EDGAR2Form S-3 - Registration statement under Securities Act of..
03/11/202307:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202307:10EDGAR2Form 8-K - Current report
03/11/202307:00GLOBEProtara Therapeutics Announces Third Quarter 2023 Financial..
23/10/202307:00GLOBEProtara Therapeutics Announces Dosing of First Patient in..
20/9/202307:30GLOBEProtara Therapeutics Announces Dosing of First Patient in..
05/9/202306:30GLOBEProtara Therapeutics to Present at the H.C. Wainwright 25th..
03/8/202307:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202307:12EDGAR2Form 8-K - Current report
03/8/202307:00GLOBEProtara Therapeutics Announces Second Quarter 2023 Financial..
18/7/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/7/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/5/202307:00GLOBEProtara Therapeutics Announces Dosing of First Patients in..

Su Consulta Reciente

Delayed Upgrade Clock